NEW YORK, June 9, 2014 /PRNewswire/ --
Today, Analysts Review released its analysts' notes regarding Precision Drilling Corporation (NYSE: PDS), Ferro Corp. (NYSE: FOE), PolyOne Corporation (NYSE: POL), Penn West Petroleum Ltd. (NYSE: PWE) and Franco-Nevada Corporation (NYSE: FNV). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/3485-100free.
--
Precision Drilling Corporation Analyst Notes
On June 3, 2014, Precision Drilling Corporation (Precision) announced the closing of its previously announced private offering of $400.0 million aggregate principal amount of 5.250% Senior Notes due 2024 (the "Notes"). The Company stated that the Notes were guaranteed on a senior unsecured basis by current and future US and Canadian subsidiaries of the Company. The full analyst notes on Precision are available to download free of charge at:
http://www.analystsreview.com/Jun-09-2014/PDS/report.pdf
--
Ferro Corp. Analyst Notes
On June 4, 2014, Ferro Corp. (Ferro) announced that it will undertake three strategic actions to advance its value creation strategy. The Company stated that it has entered into a definitive agreement with A. Schuman, Inc. to sell substantially all of the assets in its Specialty Plastics business for $91 million in cash which will approximately result into net proceeds of $87 million - to be used to pay debt. Ferro informed that it has launched a process to market its Polymer Additives business in order to improve the financial performance of the Company by building on its core competencies in glass and color technologies. The Company also announced plans of refinancing its existing $250 million 7.875% Senior Notes due in 2018 with long-term debt and is negotiating with its bank group to refinance its revolving credit facility. The full analyst notes on Ferro are available to download free of charge at:
http://www.analystsreview.com/Jun-09-2014/FOE/report.pdf
--
PolyOneCorporation Analyst Notes
On June 2, 2014, PolyOne Corporation (PolyOne) announced that it has been chosen by Biomerics as the exclusive distributor for its Quadrathane, Quadraflex, and Quadraplast medical-grade thermoplastic polyurethanes in North America. The Company informed that, Thermoplastic polyurethanes are used in a variety of medical device applications vascular access catheters, introducers, drainage catheters and interventional radiology devices. According to Mark Crist, President, PolyOne Distribution, the Biomerics' Quadra biomaterials greatly complement the Company's healthcare portfolio and will further enhance the Company's ability to help customers accelerate speed-to-market, meet or exceed product performance requirements, and fasten regulatory approvals. Travis Sessions, CEO of Biomerics, said, "Biomerics chose PolyOne Distribution to increase access of our materials and technology to the larger healthcare market. Given its strong market presence and specialty portfolio, PolyOne Distribution was a natural fit." The full analyst notes on PolyOne are available to download free of charge at:
http://www.analystsreview.com/Jun-09-2014/POL/report.pdf
--
Penn West Petroleum Ltd. Analyst Notes
On June 4, 2014, Penn West Petroleum Ltd. (Penn West) announced the voting results of the Company's Annual General Meeting of Shareholders held on June 4, 2014, which approved all resolutions outlined in the Notice of 2014 Annual General Meeting and Management Proxy Circular dated May 1, 2014. According to the voting results, eight nominees were elected as Directors of the Corporation to hold office until the next annual meeting of shareholders, namely James E. Allard, George H. Brookman, John Brydson, Giilian H. Denham, Richard L. George, David E. Roberts, James C. Smith, and Jay W. Thornton. The Company added that in the meeting, an advisory resolution regarding the Company's approach to executive compensation was also approved. In addition, the Company informed that KPMG LLP, Chartered Accountants, will be its auditor for the ensuing year. The full analyst notes on Penn West are available to download free of charge at:
http://www.analystsreview.com/Jun-09-2014/PWE/report.pdf
--
Franco-Nevada Corporation Analyst Notes
On June 4, 2014, Franco-Nevada Corporation's (Franco-Nevada) stock increased 0.97%, ending the day $46.79. Over the previous three trading sessions, shares of the Company increased 0.54% compared with S&P 500 which also increased 0.22% during the same trading period. The full analyst notes on Franco-Nevada are available to download free of charge at:
http://www.analystsreview.com/Jun-09-2014/FNV/report.pdf
--
About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.
===============
EDITOR'S NOTES:
===============
1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.
5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.
6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
AnalystsReview.com
SOURCE Analysts Review
